J. Wood Capital Advisors Llc - Oct 14, 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)

Filing Manager: J. WOOD CAPITAL ADVISORS LLC
Reporting Manager: J. Wood Capital Advisors LLC
Security: Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value
Symbol: KPTI
Shares outstanding: 20.1M shares
Disclosed Ownership: 1M shares
Ownership: 4.99%
Form type: SCHEDULE 13G/A
Date filed: 11/3/2025, 04:30 PM
Date of event: Oct 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
J. Wood Capital Advisors LLC	4.99%	1M	0	1M	/s/ Jason Wood	Jason Wood, Chief Executive Officer
Jason Wood	4.99%	1M	0	1M	/s/ Jason Wood	Jason Wood